Provided by Tiger Fintech (Singapore) Pte. Ltd.

Kymera Therapeutics, Inc.

46.18
-0.1700-0.37%
Post-market: 46.180.00000.00%17:31 EDT
Volume:501.45K
Turnover:23.29M
Market Cap:3.24B
PE:-14.84
High:47.30
Open:46.74
Low:46.00
Close:46.35
Loading ...
Jun 27, 2025

Major Issues Report

Form 8-K - Current report
Jun 27, 2025

Major Issues Report

Form 8-K - Current report
Jun 25, 2025

Major Issues Report

Form 8-K - Current report
Jun 25, 2025

Major Issues Report

Form 8-K - Current report
Jun 11, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 03, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 03, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 03, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 03, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 02, 2025

Major Issues Report

Form 8-K - Current report
Jun 02, 2025

Major Issues Report

Form 8-K - Current report
May 23, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 09, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 09, 2025

Major Issues Report

Form 8-K - Current report
Mar 03, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 03, 2025

Major Issues Report

Form 8-K - Current report
Mar 03, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 03, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 03, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 27, 2025

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans